Impact of Concentrative Nucleoside Transporter 1 Gene Polymorphism on Oral Bioavailability of Mizoribine in Stable Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Impact of Concentrative Nucleoside Transporter 1 Gene Polymorphism on Oral Bioavailability of Mizoribine in Stable Kidney Transplant Recipients

Published:2009-11 Issue: Volume: Page:
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:

Author:

Naito Takafumi,Tokashiki Shunsuke,Mino Yasuaki,Otsuka Atsushi,Ozono Seiichiro,Kagawa Yoshiyuki,Kawakami Junichi

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference30 articles.

1. Long-term results in mizoribine-treated renal transplant recipients: a prospective, randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression;Tanabe;Transplant Proc,1999

2. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis;Yumura;Clin Nephrol,2005

3. A randomized open-label comparative study of conventional therapy versus mizoribine only therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey);Shibasaki;Clin Exp Nephrol,2004

4. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis;Kawai;J Rheumatol,2006

5. New immunosuppressive drugs in organ transplantation;Hughes;J Clin Pharmacol,1996

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice;Nature Communications;2023-06-01

2. Genetic and clinical determinants of mizoribine pharmacokinetics in renal transplant recipients;European Journal of Clinical Pharmacology;2020-08-15

3. Functional disruption of pyrimidine nucleoside transporter CNT1 results in a novel inborn error of metabolism with high excretion of uridine and cytidine;Journal of Inherited Metabolic Disease;2019-04-08

4. Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients;European Journal of Clinical Pharmacology;2018-11-01

5. Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo;Drug Metabolism and Pharmacokinetics;2018-10